Wegovy hits the People’s Republic, at last
China mainlines “Musk’s miracle medicine”, at a fraction of the cost in America
IT IS KNOWN in China as “Musk’s miracle medicine”. In 2022 the boss of Tesla and new owner of Twitter, now X, gave credit for his slimmer figure to Wegovy, a drug manufactured by Novo Nordisk, a Danish firm. News about the drug quickly went viral on Chinese social media, where Mr Musk is wildly popular. The hype was, unusually, justified. Wegovy’s active ingredient, semaglutide, belongs to a class of drugs known as GLP-1 receptor agonists. GLP-1s help control blood sugar and promise to bring many other benefits as well.
Explore more
This article appeared in the China section of the print edition under the headline “The weight is over”
From the November 30th 2024 edition
Discover stories from this section and more in the list of contents
Explore the edition
China’s leaders reveal their plan to cope with 2025
Beating trade wars and deflation and boosting science are priorities
This week is a moment of truth for Xi Jinping on deflation
The budget will show how the Party plans to tackle the dangers China faces
The AfD’s unusual China connection
Alice Weidel, leader of Germany’s AfD, spent six years in the People’s Republic
Who works where, doing what, in China
A surprising new census shows a workforce being transformed
Could there be Chinese troops in Europe?
China’s leaders now talk of “a window of opportunity for peace”
Chinese authorities try to stop parents gaming the exam system (again)
They will go to great lengths to try